Ew Healthcare Partners Fund 2, L.P.'s Form 4/A amendment
AmendedTELA Bio, Inc. (TELA) · filed Sep 20, 2021
- Accession no.
- 0000899243-21-036633
- Filed
- Sep 20, 2021, 6:31 PM ET
- Trade date
- Sep 15, 2021
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Sep 17, 2021
This filing lists 1 non-derivative transaction. Open-market purchases total $124.3K. It was filed 5 days after the trade.
This amendment replaces 0000899243-21-036434 (filed Sep 17, 2021).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ew Healthcare Partners Fund 2, L.P.CIK 0001746777 | Other: See footnote 2 |
| Ew Healthcare Partners Fund 2-A, L.P.CIK 0001746779 | Other: See footnote 2 |
| EW Healthcare Partners Fund 2 GP, L.P.CIK 0001793943 | 10% Owner |
| EW Healthcare Partners Fund 2-UGP, LLCCIK 0001793948 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +10,000 | $12.43 | +$124,300 | 1,832,048 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on the date set forth above. Fund 2 purchased 4,045 shares of the amount shown above and Fund 2-A purchased 5,955 shares of the amount shown above. Fund 2 now holds a total of 761,160 shares and Fund 2-A now holds a total of 1,070,888 shares of the Issuer.
- F2
EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.
- F3
This Amended Form 4 is filed only to correct the date set forth in the original Form 4 filed on September 17, 2021. No other change has been made to the original Form 4 filed on September 17, 2021 relating to the trade made on September 15, 2021.